Welcome to our dedicated page for Archimedes Tech SPAC Partners II news (Ticker: ATII), a resource for investors and traders seeking the latest updates and insights on Archimedes Tech SPAC Partners II stock.
Archimedes Tech SPAC Partners II Co. reports developments as a blank-check company with ordinary shares and warrants traded under ATII and ATIIW. Recurring news categories include shareholder voting matters, material agreements, capital-structure disclosure, and SPAC security mechanics such as units, warrants, redemption items, and extension-related votes.
Company updates also cover operating and financial results within its pre-combination issuer structure, along with governance matters tied to its status as a special purpose acquisition company.
Archimedes Tech SPAC Partners II (Nasdaq: ATII) filed a Registration Statement on Form S-4 with the SEC on May 5, 2026, related to its previously announced proposed business combination with Forge Nano. The filing includes a preliminary proxy statement/prospectus and has not yet been declared effective.
The Registration Statement (File No. 333-295563) was filed by ATII Holdings Inc. (Pubco) and Forge Nano and is available free at the SEC website.
Archimedes Tech SPAC Partners III Co announced an upsized initial public offering of 24,000,000 units at $10.00 per unit, producing $240 million in gross proceeds. Each unit contains one ordinary share and one-fourth of a redeemable warrant; whole warrants allow purchase of one ordinary share at $11.50. Units are expected to begin trading on Nasdaq under ARCIU on January 23, 2026; ordinary shares and warrants are expected to trade separately as ARCI and ARCIW when separated. The underwriter BTIG has a 45-day option to buy up to 3,600,000 additional units to cover over-allotments. The offering is expected to close January 26, 2026, and the SEC declared the registration statement effective on January 22, 2026.
Archimedes Tech SPAC Partners II Co. (Nasdaq: ATIIU) has announced that starting April 3, 2025, investors who hold units from the company's initial public offering can begin trading ordinary shares and warrants separately. The separated components will trade on The Nasdaq Global Market under the symbols ATII (ordinary shares) and ATIIW (warrants), while unseparated units will continue trading as ATIIU.
To separate units into ordinary shares and warrants, unit holders must contact their brokers to coordinate with Odyssey Transfer and Trust Company, the company's transfer agent. Only whole warrants will be traded, with no fractional warrants being issued. The unit offering was conducted through BTIG, , with a registration statement (333-282885) declared effective by the SEC on February 10, 2025.
Archimedes Tech SPAC Partners II has successfully completed its initial public offering (IPO), raising $230 million in gross proceeds through the sale of 23 million units at $10.00 per unit. The offering included a fully exercised over-allotment option of 3 million units.
The units, trading under symbol ATIIU on Nasdaq, consist of one ordinary share and one-half redeemable warrant. Each whole warrant allows holders to purchase one ordinary share at $11.50. The ordinary shares and warrants will eventually trade separately under symbols ATII and ATIIW respectively. BTIG, served as the sole book-running manager for the IPO.
Archimedes Tech SPAC Partners II Co. has announced the pricing of its $200 million initial public offering, consisting of 20,000,000 units at $10.00 per unit. Each unit includes one ordinary share and one-half redeemable warrant, with whole warrants exercisable at $11.50 per share.
The units will trade on Nasdaq under 'ATIIU' starting February 11, 2025, while the ordinary shares and warrants will later trade separately under 'ATII' and 'ATIIW' respectively. BTIG, is the sole book-running manager and has a 45-day option to purchase up to 3,000,000 additional units for over-allotments. The offering is expected to close on February 12, 2025.